Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 5
1978 3
1982 1
1983 2
1984 3
1986 2
1987 2
1988 2
1989 2
1990 5
1991 4
1992 5
1993 4
1994 3
1995 7
1996 5
1997 4
1998 6
1999 6
2000 10
2001 7
2002 6
2003 8
2004 4
2005 7
2006 6
2007 10
2008 11
2009 11
2010 11
2011 10
2012 8
2013 12
2014 14
2015 28
2016 14
2017 12
2018 10
2019 4
2020 6
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

257 results
Results by year
Filters applied: . Clear all
Page 1
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
Morschhauser F, Flinn IW, Advani R, Sehn LH, Diefenbach C, Kolibaba K, Press OW, Salles G, Tilly H, Chen AI, Assouline S, Cheson BD, Dreyling M, Hagenbeek A, Zinzani PL, Jones S, Cheng J, Lu D, Penuel E, Hirata J, Wenger M, Chu YW, Sharman J. Morschhauser F, et al. Among authors: press ow. Lancet Haematol. 2019 May;6(5):e254-e265. doi: 10.1016/S2352-3026(19)30026-2. Epub 2019 Mar 29. Lancet Haematol. 2019. PMID: 30935953 Free article. Clinical Trial.
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.
Pfeifer M, Zheng B, Erdmann T, Koeppen H, McCord R, Grau M, Staiger A, Chai A, Sandmann T, Madle H, Dörken B, Chu YW, Chen AI, Lebovic D, Salles GA, Czuczman MS, Palanca-Wessels MC, Press OW, Advani R, Morschhauser F, Cheson BD, Lenz P, Ott G, Polson AG, Mundt KE, Lenz G. Pfeifer M, et al. Among authors: press ow. Leukemia. 2015 Jul;29(7):1578-86. doi: 10.1038/leu.2015.48. Epub 2015 Feb 24. Leukemia. 2015. PMID: 25708834 Free article.
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.
Gopal AK, Press OW, Shustov AR, Petersdorf SH, Gooley TA, Daniels JT, Garrison MA, Gjerset GF, Lonergan M, Murphy AE, Smith JC, Pagel JM. Gopal AK, et al. Among authors: press ow. Leuk Lymphoma. 2010 Aug;51(8):1523-9. doi: 10.3109/10428194.2010.491137. Leuk Lymphoma. 2010. PMID: 20578815 Free PMC article. Clinical Trial.
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, Patel MR, Sangha R, Hagenbeek A, Advani R, Tilly H, Casasnovas O, Press OW, Yalamanchili S, Kahn R, Dere RC, Lu D, Jones S, Jones C, Chu YW, Morschhauser F. Palanca-Wessels MC, et al. Among authors: press ow. Lancet Oncol. 2015 Jun;16(6):704-15. doi: 10.1016/S1470-2045(15)70128-2. Epub 2015 Apr 27. Lancet Oncol. 2015. PMID: 25925619 Clinical Trial.
Radioimmunotherapy of human tumours.
Larson SM, Carrasquillo JA, Cheung NK, Press OW. Larson SM, et al. Among authors: press ow. Nat Rev Cancer. 2015 Jun;15(6):347-60. doi: 10.1038/nrc3925. Nat Rev Cancer. 2015. PMID: 25998714 Free PMC article. Review.
Whither Radioimmunotherapy: To Be or Not To Be?
Green DJ, Press OW. Green DJ, et al. Among authors: press ow. Cancer Res. 2017 May 1;77(9):2191-2196. doi: 10.1158/0008-5472.CAN-16-2523. Epub 2017 Apr 20. Cancer Res. 2017. PMID: 28428282 Free PMC article. Review.
Immunotoxins.
Press OW. Press OW. Biotherapy. 1991;3(1):65-76. doi: 10.1007/BF02175100. Biotherapy. 1991. PMID: 2009215 Review.
Immunotherapy of Non-Hodgkin's lymphomas.
Press OW, Leonard JP, Coiffier B, Levy R, Timmerman J. Press OW, et al. Hematology Am Soc Hematol Educ Program. 2001:221-40. doi: 10.1182/asheducation-2001.1.221. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722986 Review.
Pretargeted radioimmunotherapy for B-cell lymphomas.
Green DJ, Pagel JM, Pantelias A, Hedin N, Lin Y, Wilbur DS, Gopal A, Hamlin DK, Press OW. Green DJ, et al. Among authors: press ow. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5598s-5603s. doi: 10.1158/1078-0432.CCR-07-1223. Clin Cancer Res. 2007. PMID: 17875795 Review.
257 results